Trilaciclib Combined With Anti-PD-1 Antibody and Chemotherapy in the Treatment of Locally Advanced TNBC
Clinical trial NCT06955156 · UNKNOWN
Trial details
- NCT number
- NCT06955156
- Sponsor
- QIAO LI
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-03
- Primary completion
- 2025-05-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.